Found 976 Presentations For Request "Activity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials"

Sort By
Integrating new treatment paradigms in breast cancer care in 2019 Educational session

HER2-positive breast cancer: Escalation and de-escalation strategies in the neo/adjuvant setting, who and when

Lecture Time
02:30 PM - 02:55 PM
Session Name
Integrating new treatment paradigms in breast cancer care in 2019
Speakers
  • Alexandru Eniu
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Alexandru Eniu
Integrating new treatment paradigms in breast cancer care in 2019 Educational session

Triple negative advanced breast cancer: Immunotherapy incorporation, who and when

Lecture Time
02:55 PM - 03:20 PM
Session Name
Integrating new treatment paradigms in breast cancer care in 2019
Speakers
  • Giuseppe Curigliano
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Giuseppe Curigliano
Integrating new treatment paradigms in breast cancer care in 2019 Educational session

HR-positive advanced breast cancer: CDK4 inhibitors, who and when

Lecture Time
03:20 PM - 03:45 PM
Session Name
Integrating new treatment paradigms in breast cancer care in 2019
Speakers
  • Shom Goel
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Shom Goel
Integrating new treatment paradigms in breast cancer care in 2019 Educational session

Discussion

Lecture Time
03:45 PM - 04:00 PM
Session Name
Integrating new treatment paradigms in breast cancer care in 2019
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
02:30 PM - 04:00 PM
To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer Challenge Your Expert session

To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer

Lecture Time
08:00 AM - 08:15 AM
Session Name
To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer
Speakers
  • Fatima Cardoso
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
08:00 AM - 08:45 AM
Authors
  • Fatima Cardoso
To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer Challenge Your Expert session

Discussion

Lecture Time
08:15 AM - 08:45 AM
Session Name
To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
08:00 AM - 08:45 AM
Management of young patients with residual disease after preoperative chemotherapy Multidisciplinary tumour board

Presentation of case/condition

Lecture Time
02:30 PM - 02:35 PM
Session Name
Management of young patients with residual disease after preoperative chemotherapy
Speakers
  • Olivia Pagani
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Olivia Pagani
Management of young patients with residual disease after preoperative chemotherapy Multidisciplinary tumour board

Addressing residual disease in 2019

Lecture Time
03:20 PM - 03:35 PM
Session Name
Management of young patients with residual disease after preoperative chemotherapy
Speakers
  • Sung-Bae Kim
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Sung-Bae Kim
Management of young patients with residual disease after preoperative chemotherapy Multidisciplinary tumour board

Surgical challenges

Lecture Time
02:35 PM - 02:50 PM
Session Name
Management of young patients with residual disease after preoperative chemotherapy
Speakers
  • Peter Dubsky
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Peter Dubsky
Management of young patients with residual disease after preoperative chemotherapy Multidisciplinary tumour board

Loco-regional radiotherapy: Shall we target the initial or residual disease burden?

Lecture Time
02:50 PM - 03:05 PM
Session Name
Management of young patients with residual disease after preoperative chemotherapy
Speakers
  • Boon Chua
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Boon Chua
Management of young patients with residual disease after preoperative chemotherapy Multidisciplinary tumour board

Treatment side effects; balancing effectiveness and long-term sequaele

Lecture Time
03:05 PM - 03:20 PM
Session Name
Management of young patients with residual disease after preoperative chemotherapy
Speakers
  • Alexandru Eniu
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
02:30 PM - 04:00 PM
Authors
  • Alexandru Eniu
Management of young patients with residual disease after preoperative chemotherapy Multidisciplinary tumour board

Discussion

Lecture Time
03:35 PM - 04:00 PM
Session Name
Management of young patients with residual disease after preoperative chemotherapy
Location
Hall 407, Singapore, Singapore, Singapore
Date
Sat, 23.11.2019
Time
02:30 PM - 04:00 PM